Keyphrases
Patient Outcomes
100%
Radiation Therapy
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Guideline-based
100%
Impact of Cancer
100%
Adherence to Guidelines
100%
Impact on Patients
100%
Cancer-specific Survival
80%
18F-FDG PET-CT
60%
Hazard Ratio
40%
Positron Emission Tomography-computed Tomography (PET-CT)
40%
Lung Cancer
40%
United States
20%
Imaging Modalities
20%
Cancer Mortality
20%
Medicare
20%
In Cancer
20%
CT-based
20%
Surveillance Epidemiology
20%
Clinical Practice Guidelines
20%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
20%
National Cancer Institute
20%
Cancer Causes
20%
End Results Program
20%
National Comprehensive Cancer Network
20%
National Guidelines
20%
National Comprehensive Cancer Network Guidelines
20%
Imaging Guidelines
20%
Nursing and Health Professions
Imaging
100%
Practice Guideline
100%
Lung Cancer
100%
Treatment Outcome
100%
Radiotherapy
83%
Fluorodeoxyglucose F 18
66%
Cancer Specific Survival
66%
Positron Emission Tomography-Computed Tomography
50%
Hazard Ratio
33%
Cancer Network
33%
Polyethylene Terephthalate
16%
Medicare
16%
National Health Organization
16%
Cancer Mortality
16%
Medicine and Dentistry
Lung Cancer
100%
Radiation Therapy
83%
Fluorodeoxyglucose F 18
66%
Cancer Specific Survival
66%
Malignant Neoplasm
50%
Positron Emission Tomography-Computed Tomography
50%
Hazard Ratio
33%
Cancer Mortality
16%
Medicare
16%
Surveillance, Epidemiology, and End Results
16%
Retrospective Study
16%
Polyethylene Terephthalate
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Fluorodeoxyglucose F 18
66%
Cancer Specific Survival
66%
Polyethylene Terephthalate
66%
Malignant Neoplasm
50%
Cancer Mortality
16%
Retrospective Study
16%
Biochemistry, Genetics and Molecular Biology
Cancer Specific Survival
100%
Positron Emission Tomography-Computed Tomography
75%
Cancer Mortality
25%
Retrospective Study
25%